GlassScriptPhysician profile
Tracy M Lin
NPI 1699138198
$1,289.00
in general payments reported to CMS, 2019-2025
13 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.44 · 2020: $65.51 · 2021: $72.08 · 2022: $377 · 2023: $311 · 2024: $292 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $296.41 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $219.92 | 2022-2025 | Miebo, Xiidra, Infuse |
| Alcon Vision LLC | $208.63 | 2020-2025 | Tryptyr, Eysuvis, Dailies Total1 |
| Sun Pharmaceutical Industries INC. | $138.46 | 2020-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $107.56 | 2021-2023 | |
| Coopervision INC. | $99.27 | 2020-2023 | Myday Contact Lens, Biofinity Contact Lens |
| Tarsus Pharmaceuticals, INC. | $61.93 | 2024-2025 | Xdemvy |
| Allergan, INC. | $45.29 | 2021-2022 | |
| Oyster Point Pharma, INC. | $34.78 | 2022-2024 | Ryzumvi, Tyrvaya |
| Abbvie INC. | $28.03 | 2022 | |
| Biotissue Holdings INC. | $21.63 | 2023 | |
| Harrow Eye, LLC | $14.13 | 2025 | Vevye |
| Sight Sciences, INC. | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.